Cargando…

A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer and is notorious for its resistance to both chemotherapy and small-molecule inhibitor targeted therapies. Subcellular targeted cancer therapy may thwart the resistance to produce a substantial effect. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mrdenovic, Stefan, Wang, Yanping, Yin, Lijuan, Chu, Gina Chia-Yi, Ou, Yan, Lewis, Michael S., Heffer, Marija, Posadas, Edwin M., Zhau, Haiyen E., Chung, Leland W. K., Edderkaoui, Mouad, Pandol, Stephen J., Wang, Ruoxiang, Zhang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236852/ https://www.ncbi.nlm.nih.gov/pubmed/37268911 http://dx.doi.org/10.1186/s12885-023-10878-3

Ejemplares similares

Targeting Burkitt lymphoma with a tumor cell–specific heptamethine carbocyanine‐cisplatin conjugate
por: Mrdenovic, Stefan, et al.
Publicado: (2019)

The Potential for Circulating Tumor Cells in Pancreatic Cancer Management
por: Pimienta, Michael, et al.
Publicado: (2017)

Cultured circulating tumor cells and their derived xenografts for personalized oncology
por: Wang, Ruoxiang, et al.
Publicado: (2016)

KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway
por: Yin, Lijuan, et al.
Publicado: (2022)

Cancer cell’s neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction
por: Yin, Liyuan, et al.
Publicado: (2020)

What are the macrophages and stellate cells doing in pancreatic adenocarcinoma?
por: Pandol, Stephen J., et al.
Publicado: (2015)

Spontaneous Cancer-Stromal Cell Fusion as a Mechanism of Prostate Cancer Androgen-Independent Progression
por: Wang, Ruoxiang, et al.
Publicado: (2012)

Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells
por: Li, Qinlong, et al.
Publicado: (2016)

Glycogen Synthase Kinase 3β: A True Foe in Pancreatic Cancer
por: Elmadbouh, Omer H. M., et al.
Publicado: (2022)

Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics
por: Chu, Gina Chia-Yi, et al.
Publicado: (2019)

Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells
por: Sun, Xiaojuan, et al.
Publicado: (2010)

Smoking and Pancreatic Disease
por: Edderkaoui, Mouad, et al.
Publicado: (2013)

Multiplexed Quantum Dot Labeling of Activated c-Met Signaling in Castration-Resistant Human Prostate Cancer
por: Hu, Peizhen, et al.
Publicado: (2011)

Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1α/OATPs signaling axis
por: Shi, Changhong, et al.
Publicado: (2014)

Detection of Live Circulating Tumor Cells by a Class of Near-Infrared Heptamethine Carbocyanine Dyes in Patients with Localized and Metastatic Prostate Cancer
por: Shao, Chen, et al.
Publicado: (2014)

RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization
por: Chu, Gina Chia-Yi, et al.
Publicado: (2014)

Convergent RANK- and c-Met-Mediated Signaling Components Predict Survival of Patients with Prostate Cancer: An Interracial Comparative Study
por: Hu, Peizhen, et al.
Publicado: (2013)

Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells
por: Zhang, Shumin, et al.
Publicado: (2010)

Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model
por: Taylan, Enes, et al.
Publicado: (2020)

Determination of Rottlerin, a Natural Protein Kinases C Inhibitor, in Pancreatic Cancer Cells and Mouse Xenografts by RP-HPLC Method
por: Lu, Qing-Yi, et al.
Publicado: (2012)

Breast Cancer MCF-7 Cells Acquire Heterogeneity during Successive Co-Culture with Hematopoietic and Bone Marrow-Derived Mesenchymal Stem/Stromal Cells
por: Wang, Ruoxiang, et al.
Publicado: (2022)

Risk factors for pancreatic cancer: underlying mechanisms and potential targets
por: Edderkaoui, Mouad, et al.
Publicado: (2014)

Circulating Fatty Objects and Their Preferential Presence in Pancreatic Cancer Patient Blood Samples
por: Wang, Ruoxiang, et al.
Publicado: (2022)

Sequestration of Intestinal Acidic Toxins by Cationic Resin Attenuates Pancreatic Cancer Progression through Promoting Autophagic Flux for YAP Degradation
por: Zhao, Guangfu, et al.
Publicado: (2022)

LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling
por: Lue, Hui-Wen, et al.
Publicado: (2011)

Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer
por: Stewart, Paul A., et al.
Publicado: (2017)

MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC)
por: Li, Ce, et al.
Publicado: (2019)

SARS-CoV-2 Dissemination Through Peripheral Nerves Explains Multiple Organ Injury
por: Fenrich, Matija, et al.
Publicado: (2020)

SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer
por: Gururajan, Murali, et al.
Publicado: (2015)

Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients
por: Liu, Shijie, et al.
Publicado: (2016)

Complex comprised of dextran magnetite and conjugated cisplatin exhibiting selective hyperthermic and controlled-release potential
por: Sonoda, Akinaga, et al.
Publicado: (2010)

Linalool Exhibits Cytotoxic Effects by Activating Antitumor Immunity
por: Chang, Mei-Yin, et al.
Publicado: (2014)

β2-Microglobulin-mediated Signaling as a Target for Cancer Therapy
por: Nomura, Takeo, et al.
Publicado: (2014)

EPLIN Downregulation Promotes Epithelial-Mesenchymal Transition in Prostate Cancer Cells and Correlates With Clinical Lymph Node Metastasis
por: Zhang, Shumin, et al.
Publicado: (2011)

MALDI TOF Mass Spectrometry Imaging of Blood Smear: Method Development and Evaluation
por: Debeljak, Željko, et al.
Publicado: (2021)

Antibody‐drug conjugate MORAb‐202 exhibits long‐lasting antitumor efficacy in TNBC PDx models
por: Furuuchi, Keiji, et al.
Publicado: (2021)

The driver role of JAK‐STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer
por: Lo, U‐Ging, et al.
Publicado: (2022)

PDGF Upregulates Mcl-1 Through Activation of β-Catenin and HIF-1α-Dependent Signaling in Human Prostate Cancer Cells
por: Iqbal, Shareen, et al.
Publicado: (2012)

JSKN003, A NOVEL BIPARATOPIC ANTI-HER2 ANTIBODY-DRUG CONJUGATE, EXHIBITS POTENT ANTITUMOR EFFICACY
por: Wang, Pilin, et al.
Publicado: (2023)

Synthesis and Antitumor Evaluation of Biotin-SN38-Valproic Acid Conjugates
por: Dai, Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2n75o0pknku99tjdco4rpgfk6u